Bioveta, a.s. (Bioveta) is a privately held pharmaceutical company. It is principally engaged in developing, manufacturing and marketing of veterinary, immunobiological, pharmaceuticals and services as well as human nutritional supplements. The company operates its business in four segments which include veterinary division, that produce veterinary immunologicals and pharmaceuticals; human division, that is involved in the development of supplement products such as candivac, dentivac, acnevac and urivac for supporting immune system, skin and dental care. In addition, Bioveta also offers quality assurance systems and supply of laboratory animals followed by research and development. The company markets its products to over 50 countries in and around Europe, Asia, America and Africa. Bioveta is an ISO 14001 certified company. Bioveta is headquartered in Ivanovice na Hane, Czech Republic.